1. All Products
  2. DORA - Oral drugs
  3. LEVETIRACETAM, 500mg/5ml, oral sol., 300ml bot.
Public Pricelist

LEVETIRACETAM, 500mg/5ml, oral sol., 300ml bot.

https://unicat.msf.org/cat/product/72184
STD DORALEVE1S3

Valid Article

Former Code(s): DORAZBE0080 Z DORALEVE3S-
Article is intended to be used with children (<12 years) ONLY.
5.1 - Antiseizure medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N03AX14
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

LEVETIRACETAM

Therapeutic Action

Antiepileptic, a pyrrolidone derivative

Indications

Epilepsy in pregnant women and in women on contraceptives

Adjunctive therapy of partial onset seizures, myoclonic seizures and generalised tonic-clonic seizures

Completion treatment following parenteral therapy with levetiracetam injectable for ongoing seizure maintenance in adults and children

Instructions for use

The oral solution is intended for paediatric use (infants and children under 6 years).

Leviteracetam does not reduce the effectiveness of implants and oral contraceptives.

Precautions for Use

Breastfeeding: administer with caution as levetiracetam is excreted in breast milk.

Storage

  • Below 25ºC
  • Oral solution: protect from light.